Unidad de Coagulopatías Hospital Universitario La Paz
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Roman, Maria Theresa Alvarez
PRESent-6, NCT06568302: The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial

Recruiting
3
150
Europe, Canada, US, RoW
SerpinPC, Activated Protein C (APC) inhibitor
ApcinteX Ltd, Centessa Pharmaceuticals plc
Hemophilia a, Hemophilia B, Hemophilia a with Inhibitor, Hemophilia B with Inhibitor
11/28
11/28
PRESent-2, NCT05789524: The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B

Active, not recruiting
2
60
Europe, Canada, US, RoW
SerpinPC, Activated Protein C (APC) inhibitor
ApcinteX Ltd, Centessa Pharmaceuticals plc
Hemophilia a, Hemophilia B
11/24
02/25
PedNet, NCT02979119: The European Paediatric Network for Haemophilia Management ( Registry)

Recruiting
N/A
4000
Europe, Canada, RoW
PedNet Haemophilia Research Foundation, Lund University Hospital
Factor VIII Deficiency, Factor IX Deficiency
12/29
12/29
NCT04158934: A Long-term Study of ADYNOVI/ADYNOVATE in Participants With Haemophilia A

Active, not recruiting
N/A
207
Europe, US, RoW
ADYNOVI/ADYNOVATE, Antihaemophilic Factor [Recombinant] PEGylated rurioctocog alfa pegol, TAK-660, BAX 855
Baxalta now part of Shire
Hemophilia A
02/30
02/30
Andersson, Nadine Gretenkort
PedNet, NCT02979119: The European Paediatric Network for Haemophilia Management ( Registry)

Recruiting
N/A
4000
Europe, Canada, RoW
PedNet Haemophilia Research Foundation, Lund University Hospital
Factor VIII Deficiency, Factor IX Deficiency
12/29
12/29

Download Options